Cannabis in Israel
Cannabis in Israel is illegal but decriminalized partially, although home use and possession of up to 15 grams and below is not enforced by the authorities but there are reports of enforcing occurring in low visibility, private places such as one's garden or private home. It is allowed for some specified medical usages. Citizens caught using cannabis in public for the first and second times cannot be arrested if no previous record of Cannabis use, but may face fines (1000 NIS (approximately $275) for first timers and 2000 NIS (approximately $550) for second timers), with the money collected from these fines going to education and rehabilitation programs.
On July 19, 2018, The Israeli Knesset approved the bill for decriminalization, although the Israeli Cannabis community insists that this is not a real decriminalization. The law went into place on April 1, 2019.
A survey in 2017 found that 27% of Israelis between the ages of 18 and 65 had consumed cannabis in the last year, up from 8.8% in 2009, the highest rates of annual cannabis usage in the world, followed by Iceland and the US at 18% and 16% respectively.
THC, the psychoactive chemical component in marijuana that causes a high, was first isolated by Israeli scientists Raphael Mechoulam of the Hebrew University in Jerusalem's Center for Research on Pain and Yechiel Gaoni of the Weizmann Institute in 1964.
Marijuana for medical use has been permitted in Israel since the early 1990s for cancer patients and those with pain-related illnesses such as Parkinson's, multiple sclerosis, Crohn's disease, other chronic pain and post-traumatic stress disorder. Patients can smoke cannabis, ingest it in liquid and caplet form, or apply it to the skin as a balm.
In 2004, the Israeli military began using Tetrahydrocannabinol (THC), one of the active ingredients in cannabis, for experimental treatment of post traumatic stress disorder (PTSD) of soldiers..
In 2012, the number of registered patients using medical cannabis was about 10,000. There are eight government-sanctioned cannabis growing operations in Israel, which distribute it for medical purposes to patients who have a license from the Ministry of Health and a prescription from an authorized doctor, via either a company's store, or in a medical center.
The Tikkun Olam Company has developed a variety of cannabis strains and marijuana-derived products that are reported to provide medical benefits. These products contain different levels of CBD and THC for optimum efficacy, depending on the medical condition they are taken for. CBD is the Cannabis substance that is believed to be an anti-inflammatory ingredient, which helps alleviate pain. THC in low levels does not cause a "high".  Tikun Olam has now developed a range of 230 different varieties and is considered one of the leading medical cannabis suppliers in the world, while the Israeli-American company Cannabics Pharmaceuticals is aiming to put the medicinal compounds of cannabis into a sustained-release capsule in standardized doses.
In 2017, it was reported that the Israeli medical cannabis industry could soon be worth "hundreds of millions of dollars", with research innovation in the area being backed by Israel's Ministry of Health. Currently there are about 26,000 registered medical cannabis users, with the number expected to double by 2018.
In April 2017, with global demand growing, Israel gave medical cannabis companies the green light to start exporting their products, with analyses estimating that the measure could generate Israel some $267 million per year. It was reported that formal legislation was coming but could take months to complete.
An inter-ministerial report said in August 2017 that exports could add 4 billion shekels to the Israeli economy.
Israel is considered to have a climate that is especially good for producing cannabis, with the "perfect level of humidity", according to Tamir Gedo, the head of BOL Pharma, one of the companies authorized to grow and distribute medical cannabis.
Research and Innovation
Israel is considered a global leader in medical cannabis research and innovation. Research and innovation in the area is supported by the Ministry of Health and currently being dedicated 8 million shekels a year, making Israel one of three countries in the world where cannabis research is sponsored by the government. Cannabis researchers have relocated to Israel to pursue their studies, including entire firms which do their cannabis research in Israel to evade onerous regulations on cannabis research in the US, where it is "easier to research heroin than cannabis". At least 15 US companies have moved their entire R&D operations onto Israeli soil.
According to iCan, an Israeli company which invests in the local cannabis market, more than 50 U.S. companies are doing cannabis research in Israel, and in 2016 they invested more than $125 million in Israeli cannabis operations.
Cannabis use is prohibited in the Israel Defense Forces (IDF). The IDF conducts random and non-random drug testing on members. In December, 2016, penalties for use by off-duty soldiers were relaxed; use would no longer automatically result in a court-martial.
Since 2014, IDF members in reserve status are authorized to use medical cannabis. Some soldiers have received prescriptions for cannabis to treat post-traumatic stress disorder (PTSD), with "the authorization and support of the Health Ministry and the Ministry of Defense".
Before 6 March, 2017, cannabis for recreational purposes was illegal. Before March 2017, those charged with public cannabis usage could have faced heavy fines or incarceration, although it was reported that in 2015 the number of arrests that had been made for that law were under 200; The New York Times noted of the previous situation that cannabis usage had long been overlooked by enforcement in Israel, but there was notable enforcement against growers and dealers.
As of 2015[update], most Israeli political parties favor legalizing marijuana for medicinal purposes. Parties represented in the Knesset that supported the legalization of medical marijuana in 2015 include the Zionist Union, the Joint List, Meretz, and Kulanu. The latter two supported decriminalization of the drug altogether. The Green Leaf Party, which had made cannabis legalization its raison d'être, has thus far never won a Knesset seat.
However, in 2017, it was the right-wing government of Benjamin Netanyahu, led by Likud and consisting of various right-wing, religious and Sefardi-interest parties that planned to decriminalize cannabis usage. Despite acute tension at the time between left- and the right-wing parties, the initiative was supported in the Knesset by parties across the political spectrum; right-wing Justice Minister Ayelet Shaked remarked that "whether one supports the use of cannabis or is opposed, it is wrong to judge cannabis users per criminal law and its derivatives", while left-wing Meretz member Tamar Zandberg also applauded the decision, calling it a "message that millions of Israelis who consume cannabis are not criminals" and "an important step but not the end of the road", while Public Security Minister Gilad Erdan said it marked a change in policy toward a rehabilitation oriented approach.
Cannabis usage remains illegal and those found using it in public could face fines or, after the fourth offense, incarceration; offenses before the fourth result in fines which go towards education and rehabilitation efforts and do not result in criminal records; the third offense results in mandatory participation in rehabilitation programs. Enforcement appears to be lax unless cannabis consumption occurs in public, high-visibility places. Israel's liberal stance on cannabis stands in contrast to the rest of the Middle East region where in some countries "drug trafficking" is punishable with death.
In April 2017, it was reported that Israel's government was considering further liberalization of laws concerning recreational usage. In November 2017, it was reported that Israeli Ministry of Health considering to withdraw its objection to making CBD component of cannabis legal. 
On April 20, 2018, Israeli pharmacies began selling cannabis oil legally under a pilot program.
As of April 1, 2019, Israel decriminalized the use of cannabis for citizens over the age of 18 when used in private. Possession of a home grown marijuana plant and buds is not a punishable offence. Adults caught in public with small amounts of cannabis are subject to a fine of approximately $275 for the first offence, and $550 if caught a second time. A third offence within seven years will open a criminal investigation. Decriminalization does not apply to soldiers, minors, or those with criminal records. However, otherwise law-abiding minors will be directed to rehabilitation programs. Activists lobbying for complete legalization do not support the new legislation, stating that the new law could promote stricter enforcement of the fines, whereas the police were hesitant to open criminal investigations on such large numbers of otherwise law-abiding citizens.
In 2013, Hagai Bar Giora, an Israeli rabbi and member of the Kashrut Department, stated in an interview with Israel's Cannabis magazine that “if you smoke it, there is no problem whatsoever.” Bar Giora noted that hempseed, being a legume, is not kosher for Passover for Ashkenazi Jews, but is for Sefardic Jews who permit eating legumes on Passover.
- Oran Lieberman, Kara Fox (6 March 2017). "Israel Makes it Official: Cannabis is not a Crime". CNN. Retrieved 28 November 2017.
- "Israel Decriminalized Cannabis (Kind Of)". Cannabis. 19 July 2018.
- "Cannabis Decriminalization Starting April 1st 2019". Cannabis. 15 July 2018.
- "Israel Drug Prevalence". The Israeli Cannabis Magazine / The Israeli Anti Drug Authority. Retrieved 5 June 2017.
- Yardena Schwartz (11 April 2017). "The Holy Land of Medical Marijuana: How a country the size of New Jersey became the epicenter of medicinal marijuana". US News. Retrieved 28 April 2017.
- Bohn, Lauren E. (2 November 2012). "Israel pushing ahead in medical marijuana industry". The Seattle Times.
- Kloosterman, Karin (29 March 2012). "Israeli medicine goes to pot". Israel 21C. Retrieved 4 November 2012.
- "News - Latest breaking UK news". Telegraph. 2013-06-07. Retrieved 2013-07-06.
- Stressed Israeli soldiers to be treated with cannabis China Daily: 2004-08-05
- "Jerusalem Post - National News". Fr.jpost.com. Retrieved 2013-07-06.[permanent dead link]
- News: ISRAELVALLEY SANTE – Les vertus du cannabis – En Israël, le « fournisseur médical » de marijuana du Ministère de la santé, Tikun Olam, prône les bienfaits de la plante controversée pour le traitement du cancer. Israelvalley.com – Site officiel de la Cambre de Commerce France-Israël, CCFI (22 November 2010). Retrieved 2012-05-19.
- "5 reasons Israel is dominating the cannabis industry". Israel 21c. 13 February 2017. Retrieved 28 November 2017.
- "Israel to decriminalize medical marijuana exports". Biz Israel. 2 April 2017. Retrieved 28 November 2017.
- Gwen Ackerman (8 November 2017). "Israel Wants to Start Exporting Its Cannabis Around the World". Bloomberg. Retrieved 28 November 2017.
- "In Israel, seeds of heady future for medical marijuana". Times of Israel. Daphne Rousseau. 27 March 2016. Retrieved 28 November 2017.
- Alex Lubben (5 March 2017). "Near-legal weed in the Middle East: Israel just decriminalized pot". Vice News. Retrieved 28 November 2017.
- Maayan Lubell (29 March 2016). "U.S. firms target investment in Israeli cannabis R&D". Reuters. Retrieved 28 November 2017.
- Yardena Schwartz (24 August 2017). "How the Booming Weed Industry is Changing American Pot". Rolling Stone. Retrieved 28 November 2017.
- Neumark & Schwartz 2009, p. 154.
- "IDF to ease up on pot-smoking soldiers", The Times of Israel, 21 December 2016
- Gavriel Fiske (22 September 2014), "IDF reservists can use medical pot: Policy only affects a few hundred reserve soldiers and does not yet apply to regular soldiers or careerists", The Times of Israel
- Ariela Bankier (July 8, 2011), "Should We Be Treating PTSD With THC?", Haaretz,
A year and a half ago, Dr. Yehuda Baruch – the chair of the Health Ministry's advisory board for medical cannabis – recognized the effectiveness of the substance for PTSD sufferers. Within a year, 142 requests by such patients for treatment were approved. Dozens of soldiers who suffer from PTSD as a result of their army service were, and continue to be, treated with medical cannabis, with the authorization and support of the Health Ministry and the Ministry of Defense.
- Rousseau, Daphne (March 27, 2016). "In Israel, seeds of a heady future for medical marijuana".
- "Israel to legalize medical cannabis this year". Biz Israel. April 2, 2017.[permanent dead link]
- Ian Fisher (5 March 2017). "Israeli Cabinet Makes Move to Decriminalize Recreational Marijuana Use". New York Times. Retrieved 28 November 2017.
- Ido Efrati, Grass roots support: Most Israeli parties favor use of medical marijuana Haaretz (March 11, 2015)
- Joshua Davidovich, Not exactly out of left field The Times of Israel (March 11, 2015)
- "Israel Officially Decriminalizes Marijuana Use". Haaretz. 5 March 2017. Retrieved 28 November 2017.
- "CBD is expected to be legal in Israel as well". Retrieved 2017-12-20.
- Max Schindler (April 17, 2018), "Medical marijuana will arrive in Israeli pharmacies in time for 4/20", Jerusalem Post
- Somerset, Sara Brittany. "Israel Decriminalizes Adult Use Cannabis During CannaTech Conference In Tel Aviv". Forbes. Retrieved 2020-01-01.
- staff, T. O. I. "Partial decriminalization of public cannabis use takes effect Sunday night". www.timesofisrael.com. Retrieved 2020-01-01.
- Peleg, Bar (2019-04-01). "Marijuana Decriminalization Goes Into Effect in Israel. What Does That Mean?". Haaretz. Retrieved 2020-01-01.
- JTA AND Aaron Kalman (June 28, 2013), "Rabbi: Weed is kosher if medicinal", Times of IsraelCS1 maint: uses authors parameter (link)
- "Kosher-Certified Medical Marijuana Products Are Coming to New York". Vice. 31 December 2015.
- Neumark, Yehuda D.; Schwartz, Hadar S. (2009), "The epidemiology of drug use and dependence in Israel", in Levav, Itzhak (ed.), Psychiatric and Behavioral Disorders in Israel, Gefen Publishing House, pp. 149–162, ISBN 9652294683
- Report on Pharmos and Raphael Mechoulam's pioneering work in 2005, by Karin Kloosterman writing for the Jewish Telegraphic Agency